-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Ngm Biopharmaceuticals Inc quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2019 to 2023.
- Ngm Biopharmaceuticals Inc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending December 31, 2023 was 82.5M shares, a 3.18% increase year-over-year.
- Ngm Biopharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 82.5M shares, a 3.18% increase from 2022.
- Ngm Biopharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 80M shares, a 3.72% increase from 2021.
- Ngm Biopharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 77.1M shares, a 12.6% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)